Published on Sunday April 01, 2018

The company has started working on new projects:

Smooth Drug Development launches a data management and biostatistics project in a research, conducted by a global Sponsor.

The company has reached important milestones in the following projects:

The Smooth Drug Development team has accomplished the final report for a study, conducted by an international pharmaceutical company. The report is under the Sponsor’s review.

On March 12-14, the Smooth Drug Development team attended Bio Europe Spring 2018, which was took place in Amsterdam, Netherlands. Our team held meetings with current Sponsors, had productive conversations with potential partners and delved into the advancements of the pharmaceutical industry.

In the nearest future the Smooth Drug Development Team will attend:

  • April 11-12, Generic Drug Forum 2018, Silver Spring, Maryland, USA.
  • April 11-13, CPhI Russia 2018, St. Petersburg.
  • April 24-26, CPhI North America, Philadelphia, Pennsylvania
  • May 20-23, MAGI Convention, Arlington, Virginia, USA
  • June 1-5, ASCO, Chicago, Illinois, USA.

Our company published a press-release, in which we discuss how Smooth Drug Development turns economic decline in the CIS into the favor of its Sponsors. You can find the press-release here.

Smooth Drug Development continue a series of public devoted to the discussion of Russian and East European clinical trials market. In March we published a review on a very harsh report, which suggest that clinical trials in Russia are embedded in patient abuse. To what extent is this statement truthful? You can read the answer in our article.